Patents Assigned to Koronis Pharmaceuticals, Incorporated
  • Prodrugs of heteroaryl compounds
    Patent number: 7982034
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: April 7, 2009
    Date of Patent: July 19, 2011
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Patent number: 7648967
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides isoguanosine nucleosides and derivatives thereof as well a method of increasing the mutation rate of a virus such as bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV).
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: January 19, 2010
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • 1,3,5-triazines for treatment of viral diseases
    Patent number: 7642247
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: January 5, 2010
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Prodrugs of heteroaryl compounds
    Patent number: 7589092
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: September 15, 2009
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20090209505
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: April 7, 2009
    Publication date: August 20, 2009
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20090192099
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: March 30, 2009
    Publication date: July 30, 2009
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic Heterocycles
    Publication number: 20080033172
    Abstract: The present invention provides compounds as well as methods of using the compounds as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: December 10, 2004
    Publication date: February 7, 2008
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • 1,3,5-Triazines for Treatment of Viral Diseases
    Publication number: 20070207973
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Application
    Filed: December 27, 2006
    Publication date: September 6, 2007
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Prodrugs of heteroaryl compounds
    Patent number: 7244732
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 17, 2007
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Patent number: 7244717
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides 5-aldehydo-uracil nucleosides and derivatives thereof, and methods of administration thereof to increase the virus mutation rate in a virally infected cell.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: July 17, 2007
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • 1,3,5-TRIAZINES FOR TREATMENT OF VIRAL DISEASES
    Publication number: 20070142310
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Application
    Filed: February 6, 2007
    Publication date: June 21, 2007
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Prodrugs of heteroaryl compounds
    Publication number: 20050014752
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: March 31, 2004
    Publication date: January 20, 2005
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexande Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris